🔎 Trials Near Me

ホーム › 心不全 › カリフォルニア州 › San Francisco

San Francisco、CAにおける心不全の臨床試験

San Franciscoとその周辺地域(約30マイル以内)の拠点で、心不全に関する29件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

ELEVATE-HFpEF Clinical Study

被験者募集中
  • Sutter Health Hospital, San Francisco
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

被験者募集中第3相
  • Research Site, San Francisco
18歳〜130歳 · 全性別 · 2026/10/02更新 · NCT06307652

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

被験者募集中第2相
  • University of California, San Francisco, San Francisco
  • University of California San Francisco UCSF, San Francisco
40歳〜84歳 · 全性別 · 2026/09/30更新 · NCT06979362

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

被験者募集中第3相
  • California Pacific Medical Center Van Ness Campus, San Francisco
18歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06736574

Alleviant ALLAY-HFrEF Study

被験者募集中
  • University of California San Francisco, San Francisco
18歳以上 · 全性別 · 2026/09/16更新 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

被験者募集中第3相
  • Kaiser Permanente, San Francisco
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

被験者募集中第3相
  • Research Site, San Francisco
40歳以上 · 全性別 · 2026/09/15更新 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

被験者募集中第3相
  • San Francisco, CA Investigative Site CON-10315, San Francisco
  • CON-10023, San Francisco, CA, San Francisco
18歳以上 · 全性別 · 2026/09/10更新 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

被験者募集中第3相
  • San Francisco, CA Investigative Site 10023, San Francisco
18歳以上 · 全性別 · 2026/09/10更新 · NCT06008197

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

被験者募集中
  • University of California, San Francisco, San Francisco
18歳以上 · 全性別 · 2026/09/02更新 · NCT03586336

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

被験者募集中第2相
  • University of California, San Francisco - Heart and Vascular Center, San Francisco
40歳〜85歳 · 全性別 · 2026/08/27更新 · NCT06793371

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

被験者募集中
  • Zuckerberg San Francisco General, San Francisco
  • University of California San Francisco, San Francisco
21歳以上 · 全性別 · 2026/08/25更新 · NCT05677100

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

被験者募集中第3相
  • Tenax Investigational Site, San Francisco
18歳〜85歳 · 全性別 · 2026/08/19更新 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

被験者募集中第3相
  • Kaiser Permanente Northern California, San Francisco
  • San Francisco V.A. Medical Center, San Francisco
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

Alleviant ALLAY-HF Study

被験者募集中
  • University of California San Francisco, San Francisco
40歳以上 · 全性別 · 2026/08/14更新 · NCT05685303

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

被験者募集中第3相
  • UC San Francisco Medical Center, San Francisco
2歳〜11歳 · 全性別 · 2026/07/24更新 · NCT06597006

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

被験者募集中第3相
  • San Francisco, CA Investigative Site FIN-10023, San Francisco
18歳以上 · 全性別 · 2026/07/10更新 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

被験者募集中
  • UCSF Medical Center, San Francisco
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

被験者募集中
  • University of California at San Francisco, San Francisco
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

被験者募集中第3相
  • UC San Francisco Medical Center, San Francisco
  • UC San Francisco Medical Center, San Francisco
6歳〜11歳 · 全性別 · 2026/05/15更新 · NCT06597019

Developing a Digital Aid to Improve ICD Decisions

被験者募集中
  • University of California, San Francisco, San Francisco
60歳以上 · 全性別 · 2026/04/27更新 · NCT07084142

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

被験者募集中
  • University of California- San Francisco, San Francisco
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

被験者募集中観察研究
  • University of California, San Francisco (UCSF), San Francisco
18歳以上 · 全性別 · 2026/03/02更新 · NCT07443670

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

被験者募集中観察研究
  • UCSF, San Francisco
18歳〜100歳 · 全性別 · 2025/12/16更新 · NCT06039176

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

被験者募集中観察研究
  • University of California, San Francisco, San Francisco
  • Kaiser Permanente San Francisco, San Francisco
22歳以上 · 全性別 · 2025/03/26更新 · NCT06378632

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

被験者募集中第1相
  • University of California San Francisco, San Francisco
18歳〜65歳 · 全性別 · 2025/02/06更新 · NCT06228924

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

被験者募集中第1/2相
  • University of California, San Francisco, San Francisco
18歳〜80歳 · 全性別 · 2024/03/26更新 · NCT04703842

他の都市における心不全の試験

San Franciscoにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。